About Elan (NYSE:ELN)
Elan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Elan (NYSE:ELN) Frequently Asked Questions
What is Elan's stock symbol?
Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN."
Who are some of Elan's key competitors?
Some companies that are related to Elan include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), Sanofi (SNY), GlaxoSmithKline (GSK), Eli Lilly and (LLY), AstraZeneca (AZN), Bayer (BAYN), Sanofi (SAN) and Celgene (CELG).
How do I buy Elan stock?
Shares of Elan can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Elan?
Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000.
MarketBeat Community Rating for Elan (ELN)MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Elan (NYSE:ELN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Elan (NYSE:ELN) Earnings History and Estimates Chart
Elan (NYSE ELN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/24/2013||Q3 2013||$0.03||($0.03)||$56.57 million||$48.60 million||View||N/A|
|7/24/2013||Q213||$0.02||($0.47)||$18.35 million||$56.30 million||View||N/A|
|4/24/2013||Q113||$0.05||$0.11||$0.10 million||$0.20 million||View||N/A|
|2/6/2013||Q412||$0.04||$0.15||$315.45 million||$271.00 million||View||N/A|
Elan (NYSE:ELN) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Elan (NYSE:ELN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Elan (NYSE ELN)
No insider trades for this company have been tracked by MarketBeat.com
Elan (NYSE ELN) News Headlines
Elan (NYSE:ELN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Elan (NYSE:ELN) Income Statement, Balance Sheet and Cash Flow Statement
Elan (NYSE ELN) Stock Chart for Tuesday, February, 20, 2018